Medtech Investing: A Survivor’s Game
This article was originally published in Start Up
Executive Summary
At Elsevier Business Intelligence's IN3 conference in October 2012, a panel of venture capital investors talked about the current difficult financing climate for medtech start-ups, although a ray of hope lights the future.